HUM vs PYXS · P/E 39, rev $117.76B vs rev $2.8M
Humana Inc (HUM) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the HUM and PYXS stock pages for the full models.
Not investment advice.